John Bakewell - May 20, 2025 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for John Bakewell
Stock symbol
TMCI
Transactions as of
May 20, 2025
Transactions value $
$0
Form type
4
Date filed
5/21/2025, 05:30 PM
Previous filing
Aug 19, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BAKEWELL JOHN K Director C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA BEACH /s/ Lisa Taylor as Attorney-in-fact for John Bakewell 2025-05-21 0001183553

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +23.9K +15.93% $0.00 174K May 20, 2025 Direct F1, F2
holding TMCI Common Stock 250K May 20, 2025 by spouse as trustee of a trust
holding TMCI Common Stock 92.3K May 20, 2025 As trustee of a trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date.
F2 Includes 23,917 restricted stock units.